Ledger.Open graph →

SEC Form D · filed January 21, 2021

Amunix Pharmaceuticals, Inc

Offering

$743K

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Otello Stampacchia · South San Francisco, CADirector Angie You · South San Francisco, CAExec · Director David Hirsch · South San Francisco, CADirector Richard Heyman · South San Francisco, CADirector James Brush · South San Francisco, CADirector Volker Schellenberger · South San Francisco, CAExec Trisha Millican · South San Francisco, CADirector James Topper · South San Francisco, CADirector Christopher Curtis · New York, NYDirector Phoung C. Vo · Tampa, FLDirector Stanley M. Gordon · Laguna Beach, CAExec · Director Daniel Rudin · New York, NYDirector Ulf Ek · London, United KingdomDirector Trung Pham · Toronto, Ontario, CanadaDirector Arpan C. Shah · Tampa, FLExec Bpeam Vi, LLC · Boston, MADirector David Lloyd · 215 Shuman Blvd #304, ILExec · Director Noland Langford · Naperville, ILDirector Noland Langford · Naperville, ILDirector S. D. Selznick · Boca Raton, FLDirector Peter J. Westmeyer · Chicago, ILDirector Blue Field Income I GP · Holladay, UTDirector Purandar Das · Burlington, MADirector Shanthi Boppana · Burlington, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗